Certican

DRUG4 trials

Sponsors

Instytut Pomnik Centrum Zdrowia Dziecka, Novartis Pharmaceuticals, Hospital Universitário São José

Conditions

Disorder Related to Renal TransplantationKidney TransplantationMedulloblastoma (recurrent or progressive)

Phase 1

Phase I study of CDK8 inhibitor RVU120 in combination with everolimus in children with recurrent or progressive Group 3 or 4 medulloblastoma; MEDWAY

Not yet recruitingCTIS2025-524031-39-00

Instytut Pomnik Centrum Zdrowia DzieckaMedulloblastoma (recurrent or progressive)

Target: 48Updated: 2026-04-23

Phase 2

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients

CompletedNCT00504543

Novartis PharmaceuticalsKidney Transplantation

Start: 2007-07-31End: 2011-04-30Updated: 2016-11-18

Phase 3

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

CompletedNCT00098241

Novartis PharmaceuticalsKidney Transplantation

Start: 2000-06-30End: 2007-03-31Target: 45Updated: 2017-02-23

Phase 4

Efficacy of Certican® in Combination With Myfortic® in Renal

Hospital Universitário São JoséDisorder Related to Renal Transplantation

Start: 2011-08-31End: 2013-06-30Target: 40Updated: 2011-07-21